Hologic (HOLX)
(Delayed Data from NSDQ)
$77.19 USD
+1.83 (2.43%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $77.17 -0.02 (-0.03%) 5:08 PM ET
3-Hold of 5 3
C Value D Growth D Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$77.19 USD
+1.83 (2.43%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $77.17 -0.02 (-0.03%) 5:08 PM ET
3-Hold of 5 3
C Value D Growth D Momentum C VGM
Zacks News
Hologic (HOLX) Stock Drops Despite Market Gains: Important Facts to Note
by Zacks Equity Research
Hologic (HOLX) reachead $75.36 at the closing of the latest trading day, reflecting a -0.03% change compared to its last close.
Hologic (HOLX) Q2 Earnings Might Rise on GYN Surgical Growth
by Zacks Equity Research
Hologic's (HOLX) second-quarter fiscal 2024 performance is likely to be driven by the GYN Surgical portfolio.
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Hologic (HOLX) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Strength in Molecular Diagnostics business and GYN Surgical is likely to have driven Hologic's (HOLX) fiscal second-quarter performance.
Hologic (HOLX) Increases Despite Market Slip: Here's What You Need to Know
by Zacks Equity Research
Hologic (HOLX) reachead $77.54 at the closing of the latest trading day, reflecting a +0.27% change compared to its last close.
Hologic's (HOLX) New Launches Aid, Macroeconomic Issues Ail
by Zacks Equity Research
Hologic's (HOLX) Breast Health segment is gaining from a broad portfolio of solutions for breast cancer care, primarily in the burgeoning spaces of radiology, breast surgery, pathology and treatment.
Hologic (HOLX) Falls More Steeply Than Broader Market: What Investors Need to Know
by Zacks Equity Research
Hologic (HOLX) concluded the recent trading session at $77.38, signifying a -0.77% move from its prior day's close.
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Will Hologic (HOLX) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Hologic (HOLX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Hologic (HOLX) Stock Moves -0.05%: What You Should Know
by Zacks Equity Research
Hologic (HOLX) reachead $76.08 at the closing of the latest trading day, reflecting a -0.05% change compared to its last close.
Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know
by Zacks Equity Research
Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Hologic (HOLX) Ascends While Market Falls: Some Facts to Note
by Zacks Equity Research
Hologic (HOLX) closed at $75.65 in the latest trading session, marking a +0.52% move from the prior day.
GE HealthCare (GEHC) Uses AI Solution to Boost Medical Imaging
by Zacks Equity Research
GE HealthCare's (GEHC) SonoSAMTrack demonstrates its pliability and applicability in ultrasound image segmentation by using NVIDIA's technology.
QIAGEN (QGEN) Partners With IPPA to Raise TB Screening Awareness
by Zacks Equity Research
QIAGEN's (QGEN) collaboration with IPPA follows the updated CDC guidelines for TB screening for immigrants in the United States.
Hologic (HOLX) Rises But Trails Market: What Investors Should Know
by Zacks Equity Research
Hologic (HOLX) concluded the recent trading session at $76.35, signifying a +0.58% move from its prior day's close.
Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.
Hologic (HOLX) Stock Declines While Market Improves: Some Information for Investors
by Zacks Equity Research
In the latest trading session, Hologic (HOLX) closed at $75.64, marking a -0.9% move from the previous day.
Why Is Waters (WAT) Up 7.9% Since Last Earnings Report?
by Zacks Equity Research
Waters (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Hologic's (HOLX) BCI Genomic Test Study Outcome Favorable
by Zacks Equity Research
Hologic's (HOLX) BCI test is the only genomic test that is approved by various national oncology guidelines.
Is Trending Stock Hologic, Inc. (HOLX) a Buy Now?
by Zacks Equity Research
Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
HOLX or EW: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
HOLX vs. EW: Which Stock Is the Better Value Option?
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.